Search results for "pies"

showing 10 items of 510 documents

Australian TESOL Teachers’ Cultural Perceptions of Students

2017

ABSTRACTOver the last decade, research in the field of Teaching English to Speakers of Other Languages (TESOL) has increasingly focused on the relationship between culture and learning. Researchers such as Kumaravadivelu (2003) have been vocal in their opposition to the practice of cultural stereotyping. In the current study, Holliday’s (2005) model of Culturism was used as a theoretical basis. Six Australian TESOL teachers were interviewed to determine the nature and extent of the cultural stereotypes that they held, particularly as they pertained to specific learning-related behaviours. A qualitative analysis of the data revealed that teachers most often grouped students in terms of natio…

Linguistics and Languagestereotypiesmedia_common.quotation_subjectOpposition (politics)ta6121Language and LinguisticsEducationCultural backgroundPerceptionCultural diversityPedagogyTESOLta516critical thinkingSociologyStudent learningmedia_common060201 languages & linguisticscultural stereotyping05 social sciences050301 education06 humanities and the artsIntercultural communicationCritical thinkingintercultural communication0602 languages and literatureplagiarism0503 educationQualitative researchJournal of Language, Identity & Education
researchProduct

Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function

2022

The number of effective systemic therapies for the treatment of advanced hepatocellular carcinoma (HCC) is rapidly increasing, and the advent of immunotherapy has changed the treatment paradigm for these patients, leading to significantly improved survival outcomes. However, many patients with HCC will continue to receive tyrosine kinase inhibitors, partly because of contraindications to immune checkpoint inhibitors. Currently, the best sequential first- and second-line systemic treatment remains elusive. Maintenance of optimal liver function is crucial, it is likely to impinge on temporary or permanent treatment discontinuation, and should also be considered when defining the treatment seq…

Liver CirrhosisTyrosine kinase inhibitorsSettore MED/12 - GastroenterologiaCarcinoma HepatocellularHepatologyDecompensation Free Survival; Hepatocellular carcinoma; Immune checkpoint inhibitor; Overall Survival; Progression Free Survival; Systemic therapies; Time to Decompensation; Time to Progression; Tyrosine kinase inhibitorsSystemic therapieHepatocellular carcinomaOverall SurvivalDecompensation Free SurvivalLiver NeoplasmsGastroenterologyTime to DecompensationTyrosine kinase inhibitorSystemic therapiesImmune checkpoint inhibitorTime to ProgressionProgression Free SurvivalHumansImmunotherapy
researchProduct

The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target?

2014

Abstract: The advent of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) represented the most important innovation in NSCLC treatment over the last years. However, despite a great initial activity, secondary mutations in the same target, or different alterations in other molecular pathways, inevitably occur, leading to the emergence of acquired resistance, in median within the first year of treatment. In this scenario, the mesenchymal-epidermal transition (cMET) tyrosine kinase receptor and its natural ligand, the hepatocyte growth factor (HGF), seem to play an important role. Indeed either the overexpression or the amplification of cMET, as well as the overexpr…

Lung NeoplasmscMETcMET; cMET-Inhibitors; EGFR-TKIs resistance; HGF; NSCLC; Targeted therapies; Molecular Medicine; Pharmacology; Drug Discovery3003 Pharmaceutical Science; Clinical BiochemistryClinical BiochemistryAntineoplastic AgentsBiologyPharmacologyNSCLCReceptor tyrosine kinaseTargeted therapiesCarcinoma Non-Small-Cell LungDrug DiscoverymedicineHumansEpidermal growth factor receptorHGFLung cancerProtein Kinase InhibitorsEGFR inhibitorsEGFR-TKIs resistancePharmacologyClinical Trials as TopicPharmacology. TherapyDrug Discovery3003 Pharmaceutical ScienceAntibodies MonoclonalProto-Oncogene Proteins c-metmedicine.diseaseMolecular medicinerespiratory tract diseasesErbB ReceptorsDrug Resistance NeoplasmProto-Oncogene Proteins c-metbiology.proteinCancer researchMolecular MedicineDrug Therapy CombinationHepatocyte growth factorcMET-InhibitorTargeted therapiecMET-InhibitorsTyrosine kinasemedicine.drug
researchProduct

Global distributions of diazotrophs Gamma-A nifH genes abundance - Depth integrated values computed from a collection of source datasets - Contributi…

2013

The MAREDAT atlas covers 11 types of plankton, ranging in size from bacteria to jellyfish. Together, these plankton groups determine the health and productivity of the global ocean and play a vital role in the global carbon cycle. Working within a uniform and consistent spatial and depth grid (map) of the global ocean, the researchers compiled thousands and tens of thousands of data points to identify regions of plankton abundance and scarcity as well as areas of data abundance and scarcity. At many of the grid points, the MAREDAT team accomplished the difficult conversion from abundance (numbers of organisms) to biomass (carbon mass of organisms). The MAREDAT atlas provides an unprecedente…

M60/5SalinityChlorophyll aDiazotrophs total biomass as carbonUniform resource locator link to source data fileNitrateCTD/RosetteLatitude of eventNiskinM55 1Temperature waterCalothrix abundance expressed in number of nifH gene copiesratio expressed in mass of carbon per amount of nifH gene copiesCalculatedtop minUnicellular cyanobacteria-B biological trait ratio expressed in mass of carbon per amount of nifH gene copiesCD132biomass as carbonTrichodesmium biomass as carbonM55/1bottom maxCTD SeabirdTemperatureDepth top/minCTD RosetteSeabirdRichelia biological trait ratio expressed in mass of carbon per amount of nifH gene copiesCalothrixSO187 2Unicellular cyanobacteria-B abundance expressed in number of nifH gene copiesTrichodesmiumEarth System ResearchMARine Ecosystem Model Intercomparison Project MAREMIPDiazotrophsLongitude of eventRichelia associated speciesSample methodCalothrix biological trait ratio expressed in mass of carbon per amount of nifH gene copiesIronBottle NiskinwaterIn situ pumpMARine Ecosystem Model Intercomparison Project (MAREMIP)Unicellular cyanobacteria-C abundance expressed in number of nifH gene copiesPhosphateWater sampleSample commentUnicellular cyanobacteria biomassUniform resource locator/link to source data filetotal biomass as carbonHeterocyst biomassUnicellular cyanobacteriaProteobacteriaDate/Time of eventMeteor 1986Richelia abundance expressed in number of nifH gene copiesUnicellular cyanobacteria CUnicellular cyanobacteria Bbiological traitSO187/2RicheliaUnicellular cyanobacteria ADEPTH waterbiomassTrichodesmium abundance expressed in number of nifH gene copiesMeteor (1986)BottleDepthEvent labelDate Time of eventTrichodesmium biological trait ratio expressed in mass of carbon per amount of nifH gene copiesUnicellular cyanobacteria-C biological trait ratio expressed in mass of carbon per amount of nifH gene copiesMeasured at sea surfaceCTDCalothrix associated speciesCharles DarwinSonneabundance expressed in number of nifH gene copiesM60 5Depth bottom/maxUnicellular cyanobacteria-A abundance expressed in number of nifH gene copiesassociated speciesProteobacteria abundance expressed in number of nifH gene copiesHeterocyst
researchProduct

Topoloģijas optimizācija stieņu sistēmu modeļiem

2021

Topoloģijas optimizācijas paņēmieni ir moderns veids lai veidot efektīvus risinājumus tehniskām problēmām. Šajā darbā tiks apskatīts topoloģijas optimizācijas piegājiens lai izveidot optimālo stieņu modeli. Stieņu modeļu sistēmas ir plaši lietotas buvmehānikā, inženierijā un var būt derīgi sadzīvē. Iegūtie rezultāti palīdzēs taupīt ražošanas materiālus, enerģiju. Stieņu sistēmu galvenais pielietojums, kas būs apskatīts ir spiesto-stieptu elementu modeļi, bet rezultāti var būt viegli adaptēti arī citiem vajadzīgiem aprēķiniem. Šajā darbā ir smalki aplūkots pilns aprēķinu cikls, kas no topoloģijas optimizācijas uzdevuma, aprēķinot to ar galīgo elementu metodi ar vairākiem pārveidojumiem tiek …

MATLABGalīgo elementu metodeMatemātikaTopoloģijas optimizācijaStieņu sistēmu modeļiSpiesto-stieptu elementu modeļi
researchProduct

Ierogamie, euritmie e ierotopie mariane in Sicilia. Il "case study" della Madonna dei Miracoli di Caltabellotta (Ag)

2021

Qual’è immagine venerata che resta come traccia mestica nella mente dei fedeli? Quella che tutto l’anno si può osservare sull’altare della chiesa o quella che solo una volta l’anno si può vedere durante la festa patronale? Partendo da queste domande in questo saggio si tracciano le origini di alcune raffigurazioni mariane siciliane, e in particolare del simulacro della Madonna del Soccorso o dei Miracoli di Caltabellotta (AG). È una ricerca ancora in nuce che propone una chiave di lettura dell’iconografia mariana inedita che partendo dall’analisi morfologica e iconografica, passando per la biologia delle immagini di warburghiana memoria, approda all’animismo e alla performance rituali. What…

Madonna dei Miracoli Madonna del Soccorso Madonne nere ierogamie euritmie ierotopie SiciliaMadonna dei Miracoli Madonna del Soccorso black Madonnas hierogamy eurythmy hierotopies SicilySettore M-DEA/01 - Discipline Demoetnoantropologiche
researchProduct

Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsm…

2020

AbstractAldehyde dehydrogenases (ALDHs) are multifunctional enzymes that oxidize diverse endogenous and exogenous aldehydes. We conducted a meta-analysis based on The Cancer Genome Atlas and Gene Expression Omnibus data and detected genetic alterations in ALDH1A1, ALDH1A3, or ALDH3A1, 86% of which were gene amplification or mRNA upregulation, in 31% of nonsmall cell lung cancers (NSCLCs). The expression of these isoenzymes impacted chemoresistance and shortened survival times in patients. We hypothesized that these enzymes provide an oxidative advantage for the persistence of NSCLC. To test this hypothesis, we used genetic and pharmacological approaches with DIMATE, an irreversible inhibito…

Male0301 basic medicineCancer ResearchLung NeoplasmsCell- och molekylärbiologiCellAldehyde dehydrogenaseKaplan-Meier EstimateMicechemistry.chemical_compound0302 clinical medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsCytotoxicityMiddle AgedAldehyde OxidoreductasesGlutathioneCancer metabolismUp-Regulation3. Good healthCancer therapeutic resistancemedicine.anatomical_structureAlkynes030220 oncology & carcinogenesisFemale[SDV.CAN]Life Sciences [q-bio]/CancerBiologyIsozymeAldehyde Dehydrogenase 1 FamilyArticle03 medical and health sciencesTargeted therapiesDownregulation and upregulationCell Line TumorGeneticsmedicineAnimalsHumansSulfhydryl CompoundsLung cancerMolecular BiologyAgedCancer och onkologiGene AmplificationRetinal DehydrogenaseGlutathioneAldehyde Dehydrogenasemedicine.diseaseXenograft Model Antitumor AssaysALDH1A1030104 developmental biologychemistryDrug Resistance NeoplasmCancer and Oncologybiology.proteinCancer researchCisplatinReactive Oxygen SpeciesCell and Molecular Biologynonsmall cell lung cancer
researchProduct

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway pr…

2020

Background and aims: Post-acute coronary syndrome (ACS) patients are at very high risk for recurrent events and mortality, despite the availability of effective pharmacological approaches. Aim of this survey was to evaluate the compliance to ESC/EAS guidelines during the management of ACS patients and the effectiveness of secondary prevention in seven European countries.Methods: By means of an online questionnaire, data on 2775 ACS patients (either acute case or follow-up patients) were collected, including data on lipid profile, medications, follow-up visit planning, screening for familial hypercholesterolemia.Results: Lipid profiles were obtained for 91% of ACS patients in the acute phase…

MaleAcute coronary syndromemedicine.medical_specialtyLow density lipoprotein cholesterolFamilial hypercholesterolemia030204 cardiovascular system & hematologyGuidelinesPatient pathwayLipid-lowering therapy03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicinemedicineGoal achievementHumansIn patientLow-density lipoprotein cholesterol030212 general & internal medicineAgedmedicine.diagnostic_testbusiness.industryAnticholesteremic AgentsStatinsDisease ManagementGeneral MedicineCholesterol LDLLipid-lowering therapiesmedicine.diseaseFemaleAcute coronary syndromeHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicineLipid profilebusinessGoals
researchProduct

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

2016

Background: Data from routine clinical practice are needed to further define the efficacy and safety of biologic medications in children with juvenile idiopathic arthritis (JIA). The aim of this analysis was to investigate the disease status, reasons for discontinuation and adverse events in Italian JIA patients treated with etanercept (ETN). Methods: In 2013, all centers of the Italian Pediatric Rheumatology Study Group were asked to make a census of patients given ETN after January 2000. Patients were classified in three groups: group 1 = patients still taking ETN; group 2 = patients discontinued from ETN for any reasons; group 3 = patients lost to follow-up while receiving ETN. All three…

MaleBiologic therapieBiologic therapies; Etanercept; Juvenile idiopathic arthritis; Pediatric rheumatology; TNF inhibitors; Adolescent; Antirheumatic Agents; Arthritis Juvenile; Child; Child Preschool; Cross-Sectional Studies; Drug Substitution; Etanercept; Female; Humans; Male; Methotrexate; Patient Outcome Assessment; Retrospective Studies; Treatment Outcome; Pediatrics Perinatology and Child Health; Rheumatology; Immunology and AllergyArthritisJuvenilePediatricsInflammatory bowel diseaseEtanerceptEtanerceptTNF inhibitorsSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineQuality of lifeRetrospective StudieImmunology and AllergyPediatric rheumatology030212 general & internal medicineChildBiologic therapies; Etanercept; Juvenile idiopathic arthritis; Pediatric rheumatology; TNF inhibitors; Pediatrics Perinatology and Child Health; Immunology and Allergy; RheumatologyDrug SubstitutionBiologic therapies; Etanercept; Juvenile idiopathic arthritis; Pediatric rheumatology; TNF inhibitors; Adolescent; Antirheumatic Agents; Arthritis Juvenile; Child; Child Preschool; Cross-Sectional Studies; Drug Substitution; Etanercept; Female; Humans; Male; Methotrexate; Patient Outcome Assessment; Retrospective Studies; Treatment Outcome; Pediatrics Perinatology and Child Health; Immunology and Allergy; RheumatologyAntirheumatic AgentPerinatology and Child Health3. Good healthTreatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAChild PreschoolAntirheumatic AgentsFemaleResearch ArticleHumanmedicine.drugBiologic therapies; Etanercept; Juvenile idiopathic arthritis; Pediatric rheumatology; TNF inhibitors; Adolescent; Antirheumatic Agents; Arthritis Juvenile; Child; Child Preschool; Cross-Sectional Studies; Drug Substitution; Etanercept; Female; Humans; Male; Methotrexate; Patient Outcome Assessment; Retrospective Studies; Treatment Outcomemedicine.medical_specialtyAdolescent03 medical and health sciencesJuvenile idiopathic arthritiRheumatologyInternal medicineBiologic therapies; Etanercept; Juvenile idiopathic arthritis; Pediatric rheumatology; TNF inhibitorsmedicineHumansPediatrics Perinatology and Child HealthAdverse effectPreschoolRetrospective StudiesCross-Sectional Studie030203 arthritis & rheumatologybusiness.industryArthritisRetrospective cohort studyJuvenile idiopathic arthritismedicine.diseaseArthritis JuvenileRheumatologyDiscontinuationPatient Outcome AssessmentBiologic therapiesCross-Sectional StudiesMethotrexatePediatrics Perinatology and Child HealthPhysical therapybusinessTNF inhibitor
researchProduct

Intravitreal therapies for non-neovascular age-related macular degeneration with intraretinal or subretinal fluid

2017

OBJECTIVE: To evaluate the efficacy of intravitreal therapies in cases of atrophic age-related macular degeneration (AMD) with subretinal or intraretinal fluid. METHODS: A retrospective review was made of the clinical charts of patients diagnosed with atrophic AMD with subretinal or intraretinal fluid. Fundus photographs and spectral-domain optical coherence tomography images were examined, and an analysis was made on the presence of fluid and its density. Neovascularisation was ruled out by fluorescein and/or indocyanine green angiography. RESULTS: The study included 14 eyes from 13 patients with a mean age of 72.64 years and a mean follow-up of 80.5 weeks. Intraretinal fluid was observed …

MaleDegeneracion macular asociada a la edad no neovascularVisual acuityTriamcinolone acetonidegenetic structuresFluido subretinianoAngiogenesis InhibitorsFundus (eye)Triamcinolone0302 clinical medicineDegeneración macular asociada a la edad no neovascular Fluido intrarretiniano Fluido subretiniano Intraretinal fluid Intravitreal therapies Non-neovascular age related macular degeneration Spectral domain optical coherence tomography Subretinal fluid Terapias intravítreas Tomografía de coherencia óptica de dominio espectralFluorescein AngiographyTomografia de coherencia optica de dominio espectralAged 80 and overmedicine.diagnostic_testSubretinal FluidExudates and TransudatesGeneral MedicineFluorescein angiographyFluido intrarretinianoBevacizumabTreatment Outcomemedicine.anatomical_structureIntravitreal InjectionsFemalemedicine.symptomIntravitreal therapiesTomography Optical Coherencemedicine.drugSubretinal fluidmedicine.medical_specialtyBevacizumabRetinal DrusenRetinaSpectral domain optical coherence tomography03 medical and health sciencesNon-neovascular age related macular degenerationRanibizumabOphthalmologymedicineHumansAgedRetinabusiness.industryMacular degenerationmedicine.diseaseTerapias intravitreaseye diseasesSurgeryWet Macular Degeneration030221 ophthalmology & optometryIntraretinal fluidsense organsRanibizumabbusiness030217 neurology & neurosurgeryArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct